BC
TXG icon

Bayforest Capital’s 10x Genomics TXG Stock Holding History

Bayforest Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5K Sell
542
-16,983
-97% -$340K 0.01% 783
2025
Q4 		$286K Sell
17,525
-54,302
-76% -$820K 0.21% 157
2025
Q3 		$840K Sell
71,827
-23,037
-24% -$300K 0.4% 33
2025
Q2 		$1.1M Buy
94,864
+69,306
+271% +$632K 0.48% 25
2025
Q1 		$223K Buy
25,558
+16,540
+183% +$209K 0.1% 368
2024
Q4 		$129K Buy
+9,018
New +$142K 0.16% 243

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayforest Capital's TXG Position: Q1 2026 in Review

Bayforest Capital reduced its 10x Genomics (TXG) stake by 97% in Q1 2026, selling an estimated $340K and leaving 542 shares worth $11.5K. The position accounts for 0.01% of the portfolio, ranked #783.

Bayforest Capital first reported a position in TXG in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.1M in Q2 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Bayforest Capital held 542 shares of 10x Genomics worth $11.5K as of Q1 2026.
  • Bayforest Capital sold 16,983 10x Genomics shares in Q1 2026, an estimated $340K.
  • 10x Genomics made up 0.01% of Bayforest Capital's portfolio in Q1 2026, its #783 holding.
  • Bayforest Capital first reported a position in 10x Genomics in Q4 2024 and has held it in 6 quarters since.
  • Bayforest Capital's 10x Genomics position peaked at $1.1M in Q2 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.